P
PZ Cormay SA
WSE:CRM
PZ Cormay SA
WSE:CRM
Price:
0.634
PLN
0.96%
Market Closed
Market Cap:
zł53.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
PZ Cormay SA
WSE:CRM
|
PL |
Multiples-Based Value
The Multiples-Based Value for PZ Cormay SA (CRM) under the Base Case is 0.817 PLN. Compared with the current market price of 0.634 PLN, the stock appears Undervalued by 22%.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CRM
Multiples-Based Value
Base Case
0.817
PLN
Undervaluation 22%
P
Multiples Across Competitors
CRM Competitors Multiples
PZ Cormay SA Competitors
PZ Cormay SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| PL |
P
|
PZ Cormay SA
WSE:CRM
|
53.4m PLN | 0.6 | -22.5 | 13.3 | -34.7 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.1T JPY | 10 | 36.5 | 26.3 | 31.6 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
56B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
28.8B CHF | 3.6 | 37.7 | 14.5 | 28.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
96.9B DKK | 3.5 | 24.8 | 13 | 15.6 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
11.9B USD | 2.9 | 28.9 | 12.3 | 17 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.3B GBP | 2.3 | 32.6 | 11.5 | 17.9 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
38.6B CNY | 8.5 | 23.4 | 21 | 21 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.4B USD | 1.1 | -15 | 16.5 | 53.4 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
872.4B JPY | 6.7 | 49.3 | 23.3 | 31.7 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
36.2B CNY | 3.7 | 21.3 | 31.4 | 31.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
